Oncologists and worldwide cancer specialists will learn more about an internationally renowned hair loss prevention system next week when Paxman Coolers Ltd travel across the pond to showcase their life-enhancing systems at the ASCO oncology exhibition in Chicago on 3-7th June.
Losing hair during chemotherapy is a devastating effect of cancer and a constant reminder of the life threatening disease. In response to this, Paxman Coolers Ltd’s scalp cooling systems reduce the risk of hair loss, improving patient’s self confidence and enabling them to retain their dignity by preventing otherwise inevitable total hair loss.
An internationally recognised method of hair retention, scalp cooling works by inducing the vaso-constriction of blood vessels in the scalp. It reduces the blood flow to the hair follicles during peak plasma concentration of the relevant chemotherapy agent - including epirubicin, FEC, FAC, docetaxel and paclitaxel.
Cancer chemotherapy affects rapidly dividing cells and at any given time 90% of human hair follicles are in the actively dividing phase. Hair loss frequently occurs due to partial or total atrophy of the hair root bulb, causing constriction of the hair shaft, which then breaks off easily.
During the treatment of cancer, a patient’s attitude plays a vital role in the treatment and self confidence is critical to this. Paxman Coolers Orbis I & II systems aim to help patients live an unrestricted life during an already traumatic time.
Between 70-90% of users do not require a wig after using the system which is already enhancing the lives of thousands of patients worldwide.
Operations Director Richard Paxman is hoping the conference will raise awareness of scalp cooling among visiting oncologists so that it becomes a common treatment practice for all chemotherapy patients worldwide.
He said: “Attending ASCO is vital to enable us to build awareness of our life-enhancing system and gain feedback from some of the most well respected and renowned oncologists in the world.
“We are working with a number of leading American oncologists and key cancer centres throughout the US and have a number of clinical trials currently ongoing globally so it’s an exciting time for us and we’re looking forward to a successful week.”
Paxman Coolers Ltd are aiming to make sure all cancer patients worldwide have information about and access to cooling systems, working in partnership with medical professionals, research centres, cancer support groups, charities and patients to continually advance scalp cooling technology.
The International ASCO Annual Meeting offers clinical discussions and workshops, as well as exhibition space, for oncologists to learn about the leading innovations in their field. The event will take place between 3-7th June 2011 at McCormick Place in Chicago, Illinois.
Paxman Coolers Ltd will be located on stand 24118. If you would like to book a meeting with one of the Paxman team at the event contact
info@paxman-coolers.co.uk or for more information visit
www.paxman-coolers.com